CoChat
Sign Up
Cited by 89Coronary Interventions and DiagnosticsTissue Engineering and Regenerative MedicinePolymer Surface Interaction Studies

Recent advances to accelerate re-endothelialization for vascular stents

Open access
Bedair, Tarek M, ElNaggar, Mahmoud A, Joung, Yoon Ki, Han, Dong Keun·2017·Journal of Tissue Engineering
DOI 10.1177/2041731417731546PMC PMC5624345
Open this paper in CoChat — free accountOpen PDF

Abstract

Cardiovascular diseases are considered as one of the serious diseases that leads to the death of millions of people all over the world. Stent implantation has been approved as an easy and promising way to treat cardiovascular diseases. However, in-stent restenosis and thrombosis remain serious problems after stent implantation. It was demonstrated in a large body of previously published literature that endothelium impairment represents a major factor for restenosis. This discovery became the driving force for many studies trying to achieve an optimized methodology for accelerated re-endothelialization to prevent restenosis. Thus, in this review, we summarize the different methodologies opted to achieve re-endothelialization, such as, but not limited to, manipulation of surface chemistry and surface topography.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/2041731417731546

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Other agents including fucoidan, laminin, hyaluronic acid, chondroitin sulfate, type 1 collagen, and VEGF have been used to improve endothelialization on the surface of nano and metal stents and thin tissues such as heart valve and blood vessels.

    “Other agents, including fucoidan (FU), laminin, hyaluronic acid (HA), chondroitin sulfate, type 1 collagen, and vascular endothelial growth factor (VEGF), have been used to improve endothelialization on the surface of nano and metal stents as well as thin tissues such as heart valve and blood vessels [231,234].”

    From Liver tissue engineering using decellularized scaffolds: Current progress, challenges, and opportunities (2024) · cites this paper as [231]

    The “Biomolecules for re-endothelialization” section (page not provided) names fucoidan, chondroitin sulfate, hyaluronic acid, laminin and collagen I as agents used to promote endothelial-cell growth. The “Surface chemistry on re-endothelialization” section also describes VEGF and fucoidan–laminin coatings on metallic substrates. The paper does not establish the claimed use of these agents on heart valves or other thin tissues, or specifically on nanostents. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

  • Fibronectin is a major component present in decellularized tissues and has been extensively used for conjugation with biomaterial surfaces to accelerate attachment, spreading, and differentiation of ECs.

    “Fibronectin, a large adhesive glycoprotein, is considered a major component present in decellularized tissues and has been extensively used for conjugation with biomaterial surfaces to accelerate the attachment, spreading, and differentiation of ECs [150,230,231].”

    From Liver tissue engineering using decellularized scaffolds: Current progress, challenges, and opportunities (2024) · cites this paper as [231]

    The “Biomolecules for re-endothelialization” section says fibronectin is a major ECM component and can be conjugated to biomaterial surfaces to promote EC attachment, spreading, and differentiation. It does not specifically identify fibronectin as a major component of decellularized tissues; the “Surface chemistry on re-endothelialization” section gives examples of its use on biomaterial surfaces. No page numbers are available in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 141

  1. [1]Elnaggar MA Joung YK Han DK Advanced stents for cardiovascular applications. In: Jo H Jun HW Shin J et al (eds) Biomedical engineering: frontier research and converging technologies. Cham: Springer International Publishing, 2016, pp. 407– 426.
  2. [2]Finegold JA Asaria P Francis DP Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organization and United Nations. Int J Cardiol 2013; 168(2): 934– 945. 23218570 PMC3819990
  3. [3]Serruys PW de Jaegere P Kiemeneij F et al A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331(8): 489– 495. 8041413
  4. [4]Holmes DR Vlietstra RE Smith HC Jr et al Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA registry of the national heart, lung, and blood institute. Am J Cardiol 1984; 53(12): C77– C81. 6233894
  5. [5]Fischman DL Leon MB Baim DS et al A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331(8): 496– 501. 8041414
  6. [6]Kim SM Park S-B Bedair TM et al The effect of solvents and hydrophilic additive on stable coating and controllable sirolimus release system for drug-eluting stent. Mater Sci Eng C Mater Biol Appl 2017; 78: 39– 46. 28576000
  7. [7]Bedair TM Kang SN Joung YK et al A promising approach for improving the coating stability and in vivo performance of biodegradable polymer-coated sirolimus-eluting stent. J Biomed Nanotechnol 2016; 12(11): 2015– 2028. 29364616
  8. [8]Bedair TM Yu SJ Im SG et al Effects of interfacial layer wettability and thickness on the coating morphology and sirolimus release for drug-eluting stent. J Colloid Interface Sci 2015; 460: 189– 199. 26319336
  9. [9]Cho Y Vu BQ Bedair TM et al Crack prevention of biodegradable polymer coating on metal facilitated by a nano-coupled interlayer. Journal of Bioactive and Compatible Polymers 2014; 29(5): 515– 526.
  10. [10]Bedair TM Cho Y Joung YK et al Biodegradable polymer brush as nanocoupled interface for improving the durability of polymer coating on metal surface. Colloids Surf B Biointerfaces 2014; 122: 808– 817. 25200098
  11. [11]Bedair TM Cho Y Kim TJ et al Reinforcement of interfacial adhesion of a coated polymer layer on a cobalt-chromium surface for drug-eluting stents. Langmuir 2014; 30(27): 8020– 8028. 24955485
  12. [12]Sharif F Hynes SO McCullagh KJA et al Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model. Gene Ther 2012; 19(3): 321– 328. 21716298
  13. [13]Carter AJ Aggarwal M Kopia GA et al Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. Cardiovasc Res 2004; 63(4): 617– 624. 15306217
  14. [14]Joner M Finn AV Farb A et al Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48(1): 193– 202. 16814667
  15. [15]Tan A Farhatnia Y de Mel A et al Inception to actualization: next generation coronary stent coatings incorporating nanotechnology. J Biotechnol 2013; 164(1): 151– 170. 23376617
  16. [16]Garg S Serruys PW Coronary stents: looking forward. J Am Coll Cardiol 2010; 56(Suppl. 10): S43– S78. 20797503
  17. [17]Windecker S Meier B Late coronary stent thrombosis. Circulation 2007; 116(17): 1952– 1965. 17965406
  18. [18]Finn AV Joner M Nakazawa G et al Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 2007; 115(18): 2435– 2441. 17438147
  19. [19]Pilgrim T Windecker S Drug-eluting stent thrombosis. Minerva Cardioangiol 2009; 57(5): 611– 620. 19838151
  20. [20]Li G Yang P Qin W et al The effect of coimmobilizing heparin and fibronectin on titanium on hemocompatibility and endothelialization. Biomaterials 2011; 32(21): 4691– 4703. 21463893
  21. [21]Boyle JP Smart RH Shirey JK Heparin in the treatment of chronic obstructive bronchopulmonary disease. Am J Cardiol 1964; 14(1): 25– 28. 14176885
  22. [22]Björk I Lindahl U Mechanism of the anticoagulant action of heparin. Mol Cell Biochem 1982; 48(3): 161– 182. 6757715
  23. [23]Linhardt RJ 2003 Claude S. Hudson award address in carbohydrate chemistry. Heparin: structure and activity. J Med Chem 2003; 46(13): 2551– 2564. 12801218
  24. [24]Hoshi RA Van Lith R Jen MC et al The blood and vascular cell compatibility of heparin-modified ePTFE vascular grafts. Biomaterials 2013; 34(1): 30– 41. 23069711 PMC4065598
  25. [25]Pan CJ Pang LQ Gao F et al Anticoagulation and endothelial cell behaviors of heparin-loaded graphene oxide coating on titanium surface. Mater Sci Eng C Mater Biol Appl 2016; 63: 333– 340. 27040227
  26. [26]Ahn YK Jeong MH Kim JW et al Preventive effects of the heparin-coated stent on restenosis in the porcine model. Catheter Cardiovasc Interv 1999; 48(3): 324– 330. 10525239
  27. [27]Boisson-Vidal C Chaubet F Chevolot L et al Relationship between antithrombotic activities of fucans and their structure. Drug Develop Res 2000; 51(4): 216– 224.
  28. [28]Matou S Helley D Chabut D et al Effect of fucoidan on fibroblast growth factor-2-induced angiogenesis in vitro. Thromb Res 2002; 106(4–5): 213– 221. 12297128
  29. [29]Park HY Han MH Park C et al Anti-inflammatory effects of fucoidan through inhibition of NF-κB, MAPK and Akt activation in lipopolysaccharide-induced BV2 microglia cells. Food Chem Toxicol 2011; 49(8): 1745– 1752. 21570441
  30. [30]Li B Lu F Wei X et al Fucoidan: structure and bioactivity. Molecules 2008; 13(8): 1671– 1695. 18794778 PMC6245444
  31. [31]Cumashi A Ushakova NA Preobrazhenskaya ME et al A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology 2007; 17(5): 541– 552. 17296677
  32. [32]Deux JF Meddahi-Pelle A Bree F et al Comparative studies on the mechanisms of action of four polysaccharides on arterial restenosis. J Biomater Sci Polym 2009; 20(5–6): 689– 702. 19323884
  33. [33]Deux JF Meddahi-Pelle A Le Blanche AF et al Low molecular weight fucoidan prevents neointimal hyperplasia in rabbit iliac artery in-stent restenosis model. Arterioscler Thromb Vasc Biol 2002; 22(10): 1604– 1609. 12377737
  34. [34]Kim JM Bae I-H Lim KS et al A method for coating fucoidan onto bare metal stent and in vivo evaluation. Prog Org Coat 2015; 78: 348– 356.
  35. [35]Roux N Brakenhielm E Freguin-Bouillant C et al Progenitor cell mobilizing treatments prevent experimental transplant arteriosclerosis. J Surg Res 2012; 176(2): 657– 665. 22341036
  36. [36]Bouvard C Galy-Fauroux I Grelac F et al Low-molecular-weight fucoidan induces endothelial cell migration via the PI3K/AKT pathway and modulates the transcription of genes involved in angiogenesis. Mar Drugs 2015; 13(12): 7446– 7462. 26694425 PMC4699248
  37. [37]Raymond M-A Desormeaux A Laplante P et al Apoptosis of endothelial cells triggers a caspase-dependent anti-apoptotic paracrine loop active on vascular smooth muscle cells. FASEB J 2004; 18(6): 705– 707. 14977881
  38. [38]Keuren JFW Wielders SJH Willems GM et al Thrombogenicity of polysaccharide-coated surfaces. Biomaterials 2003; 24(11): 1917– 1924. 12615482
  39. [39]Tian WM Zhang CL Hou SP et al Hyaluronic acid hydrogel as Nogo-66 receptor antibody delivery system for the repairing of injured rat brain: in vitro. J Control Release 2005; 102(1): 13– 22. 15653130
  40. [40]Markwald RR Fitzharris TP Bernanke DH Morphologic recognition of complex carbohydrates in embryonic cardiac extracellular matrix. J Histochem Cytochem 1979; 27(8): 1171– 1173. 479561
  41. [41]Schanté CE Zuber G Herlin C et al Chemical modifications of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical applications. Carbohyd Polym 2011; 85(3): 469– 489.
  42. [42]You H Lee E-U Kim Y-K et al Biocompatibility and resorption pattern of newly developed hyaluronic acid hydrogel reinforced three-layer poly (lactide-co-glycolide) membrane: histologic observation in rabbit calvarial defect model. Biomater Res 2014; 18: 12. 26331063 PMC4552410
  43. [43]Verheye S Markou CP Salame MY et al Reduced thrombus formation by hyaluronic acid coating of endovascular devices. Arterioscler Thromb Vasc Biol 2000; 20(4): 1168– 1172. 10764689
  44. [44]Masson JF Battaglia TM Davidson MJ et al Biocompatible polymers for antibody support on gold surfaces. Talanta 2005; 67(5): 918– 925. 18970259
  45. [45]Liu X Huang R Su R et al Grafting hyaluronic acid onto gold surface to achieve low protein fouling in surface plasmon resonance biosensors. ACS Appl Mater Interfaces 2014; 6(15): 13034– 13042. 25026640
  46. [46]Bauer S Arpa-Sancet MP Finlay JA et al Adhesion of marine fouling organisms on hydrophilic and amphiphilic polysaccharides. Langmuir 2013; 29(12): 4039– 4047. 23425225
  47. [47]Ramadan MH Prata JE Karacsony O et al Reducing protein adsorption with polymer-grafted hyaluronic acid coatings. Langmuir 2014; 30(25): 7485– 7495. 24892924
  48. [48]Ho CT Chen Q Shi H et al Antioxidative effect of polyphenol extract prepared from various Chinese teas. Prev Med 1992; 21(4): 520– 525. 1409493
  49. [49]Abu-Amsha Caccetta R Burke V Mori TA et al Red wine polyphenols, in the absence of alcohol, reduce lipid peroxidative stress in smoking subjects. Free Radic Biol Med 2001; 30(6): 636– 642. 11295361
  50. [50]Stangl V Dreger H Stangl K et al Molecular targets of tea polyphenols in the cardiovascular system. Cardiovasc Res 2007; 73(2): 348– 358. 17020753
  51. [51]Inoue M Suzuki R Sakaguchi N et al Selective induction of cell death in cancer cells by gallic acid. Biol Pharm Bull 1995; 18(11): 1526– 1530. 8593472
  52. [52]Kang MS Oh JS Kang IC et al Inhibitory effect of methyl gallate and gallic acid on oral bacteria. J Microbiol 2008; 46(6): 744– 750. 19107406
  53. [53]Kratz JM Andrighetti-Frohner CR Leal PC et al Evaluation of anti-HSV-2 activity of gallic acid and pentyl gallate. Biol Pharm Bull 2008; 31(5): 903– 907. 18451516
  54. [54]Kim SH Jun CD Suk K et al Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicol Sci 2006; 91(1): 123– 131. 16322071
  55. [55]Chen HM Wu YC Chia YC et al Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS-mediated anti-cancer activity in human prostate cancer cells. Cancer Lett 2009; 286(2): 161– 171. 19589639
  56. [56]Inoue M Sakaguchi N Isuzugawa K et al Role of reactive oxygen species in gallic acid-induced apoptosis. Biol Pharm Bull 2000; 23(10): 1153– 1157. 11041242
  57. [57]Qiu X Takemura G Koshiji M et al Gallic acid induces vascular smooth muscle cell death via hydroxyl radical production. Heart Vessels 2000; 15(2): 90– 99. 11199510
  58. [58]He Y Wang J Yan W et al Gallic acid and gallic acid-loaded coating involved in selective regulation of platelet, endothelial and smooth muscle cell fate. RSC Adv 2014; 4(1): 212– 221.
  59. [59]Von der Mark K Park J Engineering biocompatible implant surfaces: part II: cellular recognition of biomaterial surfaces: lessons from cell–matrix interactions. Prog Mater Sci 2013; 58(3): 327– 381.
  60. [60]Wang C-H Wang T-M Young T-H et al The critical role of ECM proteins within the human MSC niche in endothelial differentiation. Biomaterials 2013; 34(17): 4223– 4234. 23489927
  61. [61]Barbucci R Magnani A Chiumiento A et al Fibroblast cell behavior on bound and adsorbed fibronectin onto hyaluronan and sulfated hyaluronan substrates. Biomacromolecules 2005; 6(2): 638– 645. 15762624
  62. [62]Lee MH Ducheyne P Lynch L et al Effect of biomaterial surface properties on fibronectin-α5β1 integrin interaction and cellular attachment. Biomaterials 2006; 27(9): 1907– 1916. 16310247
  63. [63]Davis DH Giannoulis CS Johnson RW et al Immobilization of RGD to 〈1 1 1〉 silicon surfaces for enhanced cell adhesion and proliferation. Biomaterials 2002; 23(19): 4019– 4027. 12162335
  64. [64]Yin Y Wise SG Nosworthy NJ et al Covalent immobilization of tropoelastin on a plasma deposited interface for enhancement of endothelialisation on metal surfaces. Biomaterials 2009; 30(9): 1675– 1681. 19157535
  65. [65]Meldal M Schoffelen S Recent advances in covalent, site-specific protein immobilization. F1000Res 2016; 5: 1– 11. PMC5022707 27785356
  66. [66]Jung Y Jeong JY Chung BH Recent advances in immobilization methods of antibodies on solid supports. Analyst 2008; 133(6): 697– 701. 18493668
  67. [67]Yang Y Qi P Wen F et al Mussel-inspired one-step adherent coating rich in amine groups for covalent immobilization of heparin: hemocompatibility, growth behaviors of vascular cells, and tissue response. ACS Appl Mater Interfaces 2014; 6(16): 14608– 14620. 25105346
  68. [68]Ma L Qin H Cheng C et al Mussel-inspired self-coating at macro-interface with improved biocompatibility and bioactivity via dopamine grafted heparin-like polymers and heparin. J Mater Chem B 2014; 2(4): 363– 375. 32261381
  69. [69]Li M Wu H Wang Y et al Immobilization of heparin/poly-L-lysine microspheres on medical grade high nitrogen nickel-free austenitic stainless steel surface to improve the biocompatibility and suppress thrombosis. Mater Sci Eng C Mater Biol Appl 2017; 73: 198– 205. 28183598
  70. [70]Thalla PK Fadlallah H Liberelle B et al Chondroitin sulfate coatings display low platelet but high endothelial cell adhesive properties favorable for vascular implants. Biomacromolecules 2014; 15(7): 2512– 2520. 24927450
  71. [71]Kim SM Park KS Lih E et al Fabrication and characteristics of dual functionalized vascular stent by spatio-temporal coating. Acta Biomater 2016; 38: 143– 152. 27109766
  72. [72]Lih E Choi SG Ahn DJ et al Optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis. J Tissue Eng 2016; 7: 2041731416683745. 28228930 PMC5308429
  73. [73]Huang R Liu X Ye H et al Conjugation of hyaluronic acid onto surfaces via the interfacial polymerization of dopamine to prevent protein adsorption. Langmuir 2015; 31(44): 12061– 12070. 26488547
  74. [74]Yang Z Xiong K Qi P et al Gallic acid tailoring surface functionalities of plasma-polymerized allylamine-coated 316L SS to selectively direct vascular endothelial and smooth muscle cell fate for enhanced endothelialization. ACS Appl Mater Interfaces 2014; 6(4): 2647– 2656. 24484285
  75. [75]Cheng XW Kuzuya M Nakamura K et al Mechanisms of the inhibitory effect of epigallocatechin-3-gallate on cultured human vascular smooth muscle cell invasion. Arterioscler Thromb Vasc Biol 2005; 25(9): 1864– 1870. 16051878
  76. [76]Isemura M Saeki K Kimura T et al Tea catechins and related polyphenols as anti-cancer agents. Biofactors 2000; 13(1–4): 81– 85. 11237204
  77. [77]Kim SY Jin YR Lim Y et al Inhibition of PDGF beta-receptor tyrosine phosphorylation and its downstream intracellular signal transduction in rat aortic vascular smooth muscle cells by kaempferol. Planta Med 2005; 71(7): 599– 603. 16041643
  78. [78]Kim DW Park YS Kim YG et al Local delivery of green tea catechins inhibits neointimal formation in the rat carotid artery injury model. Heart Vessels 2004; 19(5): 242– 247. 15372300
  79. [79]Lu LH Lee SS Huang HC Epigallocatechin suppression of proliferation of vascular smooth muscle cells: correlation with c-jun and JNK. Br J Pharmacol 1998; 124(6): 1227– 1237. 9720795 PMC1565482
  80. [80]Chyu KY Babbidge SM Zhao X et al Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice. Circulation 2004; 109(20): 2448– 2453. 15136500
  81. [81]He T Yang Z Chen R et al Enhanced endothelialization guided by fibronectin functionalized plasma polymerized acrylic acid film. Mater Sci Eng C Mater Biol Appl 2012; 32(5): 1025– 1031.
  82. [82]Wang X Liu T Chen Y et al Extracellular matrix inspired surface functionalization with heparin, fibronectin and VEGF provides an anticoagulant and endothelialization supporting microenvironment. Appl Surf Sci 2014; 320: 871– 882.
  83. [83]Han F Jia X Dai D et al Performance of a multilayered small-diameter vascular scaffold dual-loaded with VEGF and PDGF. Biomaterials 2013; 34(30): 7302– 7313. 23830580
  84. [84]Shin YM Lee YB Kim SJ et al Mussel-inspired immobilization of Vascular Endothelial Growth Factor (VEGF) for enhanced endothelialization of vascular grafts. Biomacromolecules 2012; 13(7): 2020– 2028. 22617001
  85. [85]Anderson SM Siegman SN Segura T The effect of Vascular Endothelial Growth Factor (VEGF) presentation within fibrin matrices on endothelial cell branching. Biomaterials 2011; 32(30): 7432– 7443. 21783250 PMC3601829
  86. [86]Choi DH Kang SN Kim SM et al Growth factors-loaded stents modified with hyaluronic acid and heparin for induction of rapid and tight re-endothelialization. Colloid Surf B 2016; 141: 602– 610. 26928466
  87. [87]Ye C Wang Y Su H et al Construction of a fucoidan/laminin functional multilayer to direction vascular cell fate and promotion hemocompatibility. Mater Sci Eng C Mater Biol Appl 2016; 64: 236– 242. 27127049
  88. [88]Tang ZY Wang Y Podsiadlo P et al Biomedical applications of layer-by-layer assembly: from biomimetics to tissue engineering. Adv Mater 2006; 18(24): 3203– 3224.
  89. [89]Decher G Hong JD Schmitt J Buildup of ultrathin multilayer films by a self-assembly process: III. Consecutively alternating adsorption of anionic and cationic polyelectrolytes on charged surfaces. Thin Solid Films 1992; 210: 831– 835.
  90. [90]Wang Y Ye C Su H et al Layer-by-layer self-assembled laminin/fucoidan films: towards better hemocompatibility and endothelialization. RSC Adv 2016; 6(61): 56048– 56055.
  91. [91]Wang HG Yin TY Ge SP et al Biofunctionalization of titanium surface with multilayer films modified by heparin-VEGF-fibronectin complex to improve endothelial cell proliferation and blood compatibility. J Biomed Mater Res A 2013; 101(2): 413– 420. 22865832
  92. [92]Liu P Zhao Y Yan Y et al Construction of extracellular microenvironment to improve surface endothelialization of NiTi alloy substrate. Mater Sci Eng C Mater Biol Appl 2015; 55: 1– 7. 26117732
  93. [93]Elnaggar MA Seo SH Gobaa S et al Nitric oxide releasing coronary stent: a new approach using layer-by-layer coating and liposomal encapsulation. Small 2016; 12(43): 6012– 6023. 27623489
  94. [94]Tanner FC Meier P Greutert H et al Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation 2000; 101(16): 1982– 1989. 10779466
  95. [95]Kapadia MR Eng JW Jiang Q et al Nitric oxide regulates the 26S proteasome in vascular smooth muscle cells. Nitric Oxide 2009; 20(4): 279– 288. 19233305
  96. [96]Gooch KJ Dangler CA Frangos JA Exogenous, basal, and flow-induced nitric oxide production and endothelial cell proliferation. J Cell Physiol 1997; 171(3): 252– 258. 9180894
  97. [97]Ishida A Sasaguri T Kosaka C et al Induction of the cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/Waf1) by nitric oxide-generating vasodilator in vascular smooth muscle cells. J Biol Chem 1997; 272(15): 10050– 10057. 9092548
  98. [98]Taylor EL Li JT Tupper JC et al GEA 3162, a peroxynitrite donor, induces Bcl-2-sensitive, p53-independent apoptosis in murine bone marrow cells. Biochem Pharmacol 2007; 74(7): 1039– 1049. 17681284 PMC1991334
  99. [99]Elnaggar MA Subbiah R Han DK et al Lipid-based carriers for controlled delivery of nitric oxide. Expert Opin Drug Deliv. Epub ahead of print 6 2 2017 DOI: 10.1080/17425247.2017.1285904. 28117595 · DOI
  100. [100]Kelm M Nitric oxide metabolism and breakdown. Biochim Biophys Acta 1999; 1411(2–3): 273– 289. 10320663
  101. [101]Mathews SM Spallholz JE Grimson MJ et al Prevention of bacterial colonization of contact lenses with covalently attached selenium and effects on the rabbit cornea. Cornea 2006; 25(7): 806– 814. 17068458
  102. [102]Hou Y Guo Z Li J et al Seleno compounds and glutathione peroxidase catalyzed decomposition of S-Nitrosothiols. Biochem Biophys Res Commun 1996; 228(1): 88– 93. 8912640
  103. [104]Freedman JE Frei B Welch GN et al Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols. J Clin Invest 96(1): 394– 400. 7615810 PMC185212
  104. [105]Weng Y Song Q Zhou Y et al Immobilization of selenocystamine on TiO2 surfaces for in situ catalytic generation of nitric oxide and potential application in intravascular stents. Biomaterials 2011; 32(5): 1253– 1263. 21093045
  105. [106]Yang Z Yang Y Xiong K et al Nitric oxide producing coating mimicking endothelium function for multifunctional vascular stents. Biomaterials 2015; 63: 80– 92. 26093790
  106. [107]Yang Z Lei X Wang J et al A novel technique toward bipolar films containing alternating nano–layers of allylamine and acrylic acid plasma polymers for biomedical application. Plasma Process Polym 2011; 8(3): 208– 214.
  107. [108]Chen S An J Weng L et al Construction and biofunctional evaluation of electrospun vascular graft loaded with selenocystamine for in situ catalytic generation of nitric oxide. Mater Sci Eng C Mater Biol Appl 2014; 45: 491– 496. 25491855
  108. [109]Wang Y Chen S Pan Y et al Rapid in situ endothelialization of a small diameter vascular graft with catalytic nitric oxide generation and promoted endothelial cell adhesion. J Mat Chem B 2015; 3(47): 9212– 9222. 32263136
  109. [110]Luo R Liu Y Yao H et al Copper-incorporated collagen/catechol film for in situ generation of nitric oxide. ACS Biomater Sci Eng 2015; 1(9): 771– 779. 33445254
  110. [111]Noble DR Swift HR Williams DLH Nitric oxide release from S-nitrosoglutathione (GSNO). Chem Commun 1999; 22: 2317– 2318.
  111. [112]Williams DLH The mechanism of nitric oxide formation from S-nitrosothiols (thionitrites). Chem Commun 1996; 10: 1085– 1091.
  112. [113]Gorren ACF Schrammel A Schmidt K et al Decomposition of S-Nitrosoglutathione in the presence of copper ions and glutathione. Arch Biochem Biophys 1996; 330(2): 219– 228. 8660650
  113. [114]Herves Beloso P Williams DLH Reversibility of S-nitrosothiol formation. Chem Commun 1997; 1: 89– 90.
  114. [116]Satriano C Lupo G Motta C et al Ferritin-supported lipid bilayers for triggering the endothelial cell response. Colloid Surf B 2017; 149: 48– 55. 27718396
  115. [117]Arosio P Adelman TG Drysdale JW On ferritin heterogeneity. Further evidence for heteropolymers. J Biol Chem 1978; 253(12): 4451– 4458. 659425
  116. [118]Moss D Powell LW Halliday JW et al Functional roles of the ferritin receptors of human liver, hepatoma, lymphoid and erythroid cells. J Inorg Biochem 47(1): 219– 227. 1331322
  117. [119]Torti SV Torti FM Iron and cancer: more ore to be mined. Nat Rev Cancer 2013; 13(5): 342– 355. 23594855 PMC4036554
  118. [120]Richter R Mukhopadhyay A Brisson A Pathways of lipid vesicle deposition on solid surfaces: a combined QCM-D and AFM study. Biophys J 2003; 85(5): 3035– 3047. 14581204 PMC1303580
  119. [121]Palmaz JC Benson A Sprague EA Influence of surface topography on endothelialization of intravascular metallic material. J Vasc Interv Radiol 1999; 10(4): 439– 444. 10229473
  120. [122]Dalby MJ Riehle MO Johnstone H et al In vitro reaction of endothelial cells to polymer demixed nanotopography. Biomaterials 2002; 23(14): 2945– 2954. 12069336
  121. [123]Choudhary S Berhe M Haberstroh KM et al Increased endothelial and vascular smooth muscle cell adhesion on nanostructured titanium and CoCrMo. Int J Nanomed 2006; 1(1): 41– 49. PMC2426766 17722261
  122. [124]Lu J Rao MP MacDonald NC et al Improved endothelial cell adhesion and proliferation on patterned titanium surfaces with rationally designed, micrometer to nanometer features. Acta Biomater 2008; 4(1): 192– 201. 17851147
  123. [125]Ding Y Yang Z Bi CWC et al Directing vascular cell selectivity and hemocompatibility on patterned platforms featuring variable topographic geometry and size. ACS Appl Mater Interfaces 2014; 6(15): 12062– 12070. 25039647
  124. [126]Oh S Daraio C Chen L-H et al Significantly accelerated osteoblast cell growth on aligned TiO2 nanotubes. J Biomed Mater Res A 2006; 78(1): 97– 103. 16602089
  125. [127]Park J Bauer S Von Mark K et al Nanosize and vitality: TiO2 nanotube diameter directs cell fate. Nano Lett 2007; 7(6): 1686– 1691. 17503870
  126. [128]Zhu X Chen J Scheideler L et al Cellular reactions of osteoblasts to micron- and submicron-scale porous structures of titanium surfaces. Cells Tissues Organs 2004; 178(1): 13– 22. 15550756
  127. [129]Brammer KS Oh S Cobb CJ et al Improved bone-forming functionality on diameter-controlled TiO(2) nanotube surface. Acta Biomater 2009; 5(8): 3215– 3223. 19447210
  128. [130]Saleh YE Gepreel MA Allam NK Functional nanoarchitectures for enhanced drug eluting stents. Sci Rep 2017; 7: 40291. 28079127 PMC5227685
  129. [131]Peng L Mendelsohn AD LaTempa TJ et al Long-term small molecule and protein elution from TiO2 nanotubes. Nano Lett 2009; 9(5): 1932– 1936. 19323554
  130. [132]Song Y-Y Schmidt-Stein F Bauer S et al Amphiphilic TiO2 nanotube arrays: an actively controllable drug delivery system. J Am Chem Soc 2009; 131(12): 4230– 4232. 19317500
  131. [133]Arnold M Cavalcanti-Adam EA Glass R et al Activation of integrin function by nanopatterned adhesive interfaces. Chem Phys Chem 2004; 5(3): 383– 388. 15067875
  132. [134]Brammer KS Oh S Gallagher JO et al Enhanced cellular mobility guided by TiO2 nanotube surfaces. Nano Lett 2008; 8(3): 786– 793. 18251515
  133. [135]Peng L Eltgroth ML LaTempa TJ et al The effect of TiO2 nanotubes on endothelial function and smooth muscle proliferation. Biomaterials 2009; 30(7): 1268– 1272. 19081625
  134. [136]Peng L Barczak AJ Barbeau RA et al Whole genome expression analysis reveals differential effects of TiO2 nanotubes on vascular cells. Nano Lett 2010; 10(1): 143– 148. 20030358 PMC2833360
  135. [137]Lee PP Cerchiari A Desai TA Nitinol-based nanotubular coatings for the modulation of human vascular cell function. Nano Lett 2014; 14(9): 5021– 5028. 25115216 PMC4945101
  136. [138]Lee PP Desai TA Nitinol-based nanotubular arrays with controlled diameters upregulate human vascular cell ECM production. ACS Biomater Sci Eng 2016; 2(3): 409– 414. 27942579 PMC5148153
  137. [139]Ding Y Yang M Yang Z et al Cooperative control of blood compatibility and re-endothelialization by immobilized heparin and substrate topography. Acta Biomater 2015; 15: 150– 163. 25541345
  138. [140]Vartanian KB Berny MA McCarty OJT et al Cytoskeletal structure regulates endothelial cell immunogenicity independent of fluid shear stress. Am J Physiol Cell Physiol 2010; 298(2): C333. 19923423
  139. [141]Zorlutuna P Rong Z Vadgama P et al Influence of nanopatterns on endothelial cell adhesion: enhanced cell retention under shear stress. Acta Biomater 2009; 5(7): 2451– 2459. 19394284
  140. [142]Yang Z Zhong S Yang Y et al Polydopamine-mediated long-term elution of the direct thrombin inhibitor bivalirudin from TiO2 nanotubes for improved vascular biocompatibility. J Mater Chem B 2014; 2(39): 6767– 6778. 32261873
  141. [143]Nie C Ma L Cheng C et al Nanofibrous heparin and heparin-mimicking multilayers as highly effective endothelialization and antithrombogenic coatings. Biomacromolecules 2015; 16(3): 992– 1001. 25668587

Cited by

Sorted by citations

Authors
Bedair, T. M., ElNaggar, M. A., Joung, Y. K., & Han, D. K.
Affiliations
  • Korea Institute of Science and Technology (KR)
  • CHA University (KR)
Corresponding author
Han, Dong Keun
ORCID
Venue
Journal of Tissue Engineering
Publisher
SAGE Publications
Published
2017-01-01
Volume
8
Pages
2041731417731546-2041731417731546
ISSN
2041-7314 (ISSN-L)
DOI
10.1177/2041731417731546
PMC
PMC5624345
OpenAlex
W2756579357
Cited by
89
References
2
Citations by year
2026: 6 · 2025: 6 · 2024: 6 · 2023: 8 · 2022: 14 · 2021: 15 · 2020: 12 · 2019: 14 · 2018: 8
FWCI
9.53
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Tissue Engineering (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Surgery › Coronary Interventions and Diagnostics
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Materials Science › Surfaces, Coatings and Films › Polymer Surface Interaction Studies
Keywords
re-endothelialization, vascular stents, in-stent restenosis, stent thrombosis, surface chemistry, surface topography, stent surface modification

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review